Insider Trading History of Jaeger Wilfred E

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Jaeger Wilfred E since 2008. The trader's CIK number is 1190474. At the time of the last reporting, Jaeger Wilfred E was the Director of Neuronetics, Inc.. (stock ticker symbol STIM). Also see all insider trading activities at Neuronetics, Inc..

Note that in the past JAEGER WILFRED E also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Neuronetics, Inc. (STIM) by Jaeger Wilfred E

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 STIM 6,667 $113,339 0 $0 0 $0

Yearly summary of insider trading at Molecular Templates, Inc. (THLD) by Jaeger Wilfred E

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 THLD 25,000 $93,625 0 $0 0 $0
2014 THLD 0 $0 1,245,212 $6,070,343 0 $0
2013 THLD 0 $0 1,000,000 $5,516,898 0 $0
2012 THLD 0 $0 1,001,000 $7,970,190 55,000 $77,000
2009 THLD 1,047,120 $1,947,643 0 $0 0 $0
2008 THLD 980,391 $1,999,997 0 $0 0 $0

Yearly summary of insider trading at Epocrates Inc (EPOC) by Jaeger Wilfred E

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 EPOC 0 $0 292,116 $4,673,856 0 $0

Yearly summary of insider trading at Liposcience Inc (LPDX) by Jaeger Wilfred E

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 LPDX 215,000 $1,935,000 0 $0 0 $0

Yearly summary of insider trading at Concert Pharmaceuticals, Inc. (CNCE) by Jaeger Wilfred E

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 CNCE 0 $0 250,000 $3,072,500 0 $0

Yearly summary of insider trading at Nevro Corp (NVRO) by Jaeger Wilfred E

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 NVRO 0 $0 200,000 $16,214,847 0 $0
2017 NVRO 0 $0 232,967 $20,176,804 0 $0
2016 NVRO 0 $0 422,983 $37,641,844 0 $0
2015 NVRO 0 $0 593,468 $29,375,187 0 $0


Insider trading activities at 6 companies by Jaeger Wilfred E:

1. Neuronetics, Inc. (STIM)

2. Molecular Templates, Inc. (THLD)

3. Epocrates Inc (EPOC)

4. Liposcience Inc (LPDX)

5. Concert Pharmaceuticals, Inc. (CNCE)

6. Nevro Corp (NVRO)

Table 1. Insider trading of Neuronetics, Inc. (STIM) by Jaeger Wilfred E

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-07-02 STIM Buy 6,667 17.00 113,339

Table 2. Insider trading of Molecular Templates, Inc. (THLD) by Jaeger Wilfred E

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-02-18 THLD Buy 25,000 3.75 93,625
2014-01-16 THLD Sale 96,356 4.86 468,001
2014-01-14 THLD Sale 98,000 4.87 476,867
2014-01-13 THLD Sale 126,956 4.89 621,449
2014-01-15 THLD Sale 200,000 4.86 971,400
2014-01-08 THLD Sale 243,900 4.90 1,194,866
2014-01-09 THLD Sale 200,000 4.87 973,600
2014-01-10 THLD Sale 280,000 4.87 1,364,160
2013-07-12 THLD Sale 232,800 5.54 1,289,479
2013-07-15 THLD Sale 89,200 5.52 492,205
2013-07-10 THLD Sale 62,000 5.50 341,062
2013-07-11 THLD Sale 116,000 5.52 640,436
2013-07-03 THLD Sale 123,700 5.56 687,772
2013-07-05 THLD Sale 95,967 5.48 525,899
2013-06-19 THLD Sale 2,000 5.50 11,006
2013-06-17 THLD Sale 53,222 5.53 294,157
2013-06-18 THLD Sale 71,511 5.50 393,382
2013-06-10 THLD Sale 53,600 5.50 294,800
2013-06-07 THLD Sale 100,000 5.47 546,700
2012-09-04 THLD Option Ex 55,000 1.40 77,000
2012-08-27 THLD Sale 286,400 7.98 2,284,612
2012-08-24 THLD Sale 500,000 8.02 4,011,000
2012-08-22 THLD Sale 59,600 7.52 447,953
2012-08-21 THLD Sale 30,000 7.50 225,000
2012-07-13 THLD Sale 125,000 8.01 1,001,625
2009-10-05 THLD Buy 1,047,120 1.86 1,947,643
2008-08-29 THLD Buy 980,391 2.04 1,999,997

Table 3. Insider trading of Epocrates Inc (EPOC) by Jaeger Wilfred E

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-02-07 EPOC Sale 292,116 16.00 4,673,856

Table 4. Insider trading of Liposcience Inc (LPDX) by Jaeger Wilfred E

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-01-30 LPDX Buy 215,000 9.00 1,935,000

Table 5. Insider trading of Concert Pharmaceuticals, Inc. (CNCE) by Jaeger Wilfred E

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-11-18 CNCE Sale 250,000 12.29 3,072,500

Table 6. Insider trading of Nevro Corp (NVRO) by Jaeger Wilfred E

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-03-05 NVRO Sale 42,116 80.19 3,377,113
2018-03-06 NVRO Sale 50,840 80.38 4,086,570
2018-03-07 NVRO Sale 67,586 81.42 5,502,987
2018-02-27 NVRO Sale 14,458 83.69 1,209,917
2018-02-28 NVRO Sale 15,000 82.23 1,233,420
2018-03-01 NVRO Sale 10,000 80.48 804,840
2017-09-14 NVRO Sale 16,467 90.01 1,482,244
2017-08-22 NVRO Sale 40,000 85.83 3,433,080
2017-08-23 NVRO Sale 5,206 87.01 452,984
2017-08-24 NVRO Sale 7,314 87.00 636,318
2017-08-17 NVRO Sale 15,343 84.02 1,289,103
2017-08-21 NVRO Sale 25,000 84.44 2,111,125
2017-08-16 NVRO Sale 24,737 83.40 2,062,991
2017-08-15 NVRO Sale 29,665 82.54 2,448,430
2017-08-14 NVRO Sale 25,255 82.40 2,081,012
2017-03-01 NVRO Sale 42,961 95.03 4,082,712
2017-03-02 NVRO Sale 300 95.00 28,500
2017-03-03 NVRO Sale 719 95.00 68,305
2016-08-18 NVRO Sale 79,840 97.52 7,785,757
2016-08-19 NVRO Sale 65,000 98.08 6,375,460
2016-08-22 NVRO Sale 10,000 99.23 992,320
2016-08-16 NVRO Sale 24,546 96.54 2,369,695
2016-08-17 NVRO Sale 30,614 96.16 2,943,689
2016-08-15 NVRO Sale 100,000 98.28 9,827,900
2016-05-16 NVRO Sale 100,000 65.07 6,507,100
2016-05-17 NVRO Sale 11,640 64.77 753,946
2016-05-18 NVRO Sale 1,343 64.02 85,977
2015-11-23 NVRO Sale 25,000 53.48 1,337,025
2015-11-17 NVRO Sale 48,368 51.94 2,512,185
2015-11-18 NVRO Sale 126,632 52.62 6,663,122
2015-06-08 NVRO Sale 393,468 47.94 18,862,855

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Jaeger Wilfred E (Director of Neuronetics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.